Search For "emergency use"
Zydus Cadila vaccine to be inoculated through applicator, not injection, s
Updated : 4 years, 7 months ago IST
New Delhi [India], October 7 (ANI): Following the approval of the Zydus Cadila vaccine by the Drugs Controller General of India (DGCI) for emergency use, Dr VK Paul, Member (Health) of Niti Aayog on Thursday said that the vaccine will be administered through an applicator which will be us
Read More
WHO decision on Covaxin nod extended to next week
Updated : 4 years, 7 months ago IST
Geneva [Switzerland], October 5 (ANI): World Health Organisation (WHO) has extended giving the emergency use authorization for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin to next week.
Read More
Vaccination of children only way to get rid of COVID pandemic: AIIMS Direc
Updated : 4 years, 7 months ago IST
New Delhi [India], October 2 (ANI): Children between 12 to 18 years of age will be vaccinated against COVID-19 very soon, said Dr Randeep Guleria, Director of All Indian Institute of Medical Sciences (AIIMS), Delhi.
Read More
WHO to give approval to Covaxin this month, say top health experts
Updated : 4 years, 7 months ago IST
New Delhi [India], October 2 (ANI): The decision on Bharat Biotech's Covid-19 vaccine, Covaxin Emergency Use Listing (EUL) by the World Health Organisation (WHO) is expected in October, informed the top health experts in the country on Saturday.
Read More
AIIMS Delhi Director hopes for early approval of COVID-19 vaccine Covaxin
Updated : 4 years, 7 months ago IST
New Delhi [India], October 1 (ANI): With the data and studies regarding COVID-19 vaccine Covaxin submitted to the World Health Organization, All India Institute of Medical Sciences (AIIMS) Delhi Director Randeep Guleria is hopeful that the authorisation for emergency use listing to the vacci
Read More
WHO to decide on Bharat Biotech's Covaxin emergency usage in October
Updated : 4 years, 7 months ago IST
New Delhi [India] September 30 (ANI): The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech's submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021.
Read More
WHO's emergency use authorisation for Covaxin further delayed: Sources
Updated : 4 years, 7 months ago IST
New Delhi [India], September 28 (ANI): The emergency use authorisation (EUA) for Bharat Biotech's COVID-19 vaccine Covaxin has once again been delayed by the World Health Organisation, said sources.
Read More
'WHO's emergency use authorization to Covaxin expected soon'
Updated : 4 years, 8 months ago IST
New Delhi [India], September 24 (ANI): The Union Health Ministry on Friday hinted that World Health Organization's emergency use authorization to Covaxin is expected soon.
Read More
WHO emergency use authorisation to Covaxin delayed till October 5
Updated : 4 years, 8 months ago IST
New Delhi [India], September 18 (ANI): World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.
Read More
Bharat Biotech awaits feedback from WHO for COVID-19 vaccine Covaxin's eme
Updated : 4 years, 8 months ago IST
New Delhi [India], September 17 (ANI): Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.
Read More
Close to a decision point, says Dr V K Paul on WHO Emergency Use Listing t
Updated : 4 years, 8 months ago IST
New Delhi [India], September 14 (ANI): The approval of Bharat Biotech's COVID-19 vaccine Covaxin for Emergency use Listing (EUL) from the World Health Organisation (WHO) is expected at any time soon, said Dr VK Paul, NITI Aayog member (Health) on Tuesday.
Read More
Zydus Cadila to seek approval for two-dose regimen of its approved three-d
Updated : 4 years, 8 months ago IST
New Delhi [India], September 12 (ANI): Considering the burden on healthcare and the expense of buying three doses, Zydus Cadila is planning to seek approval for the two-dose regimen of its needle-free COVID-19 vaccine, ZyCoV-D, days after the vaccine was approved by India's drugs regulator f
Read More